Synergistic promotion of blood vessel regeneration by astragaloside IV and ferulic acid from electrospun fibrous mats

Molecular Pharmaceutics

Volumn 10, Issue 6, 2013, Pages 2394-2403

  Wang, Huan ^a,b   Zhang, Yun ^a   Xia, Tian ^c   Wei, Wei ^c   Chen, Fang ^a   Guo, Xueqin ^a   Li, Xiaohong ^a,b  

^a State Key Laboratory of New Ceramics and Fine Processing   (China)

^b SOUTHWEST JIAOTONG UNIVERSITY   (China)

^c 452nd Hospital of People's Liberation Army   (China)

Author keywords

blood vessel; electrospun fibers; tissue engineering scaffold; traditional Chinese medicine

Indexed keywords

ASTRAGALOSIDE IV; ELECTROSPUN FIBROUS SCAFFOLD; FERULIC ACID; TISSUE SCAFFOLD; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CELL DENSITY; CELL MATURATION; CELL VIABILITY; CHINESE MEDICINE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG POTENTIATION; DRUG RELEASE; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; TISSUE ENGINEERING; VASCULARIZATION;

BLOOD VESSELS; CELL SURVIVAL; CELLS, CULTURED; COUMARIC ACIDS; DRUG SYNERGISM; HUMANS; REGENERATION; SAPONINS; TISSUE ENGINEERING; TRITERPENES;

EID: 84878649292     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp400031y     Document Type: Article

References (42)

1. Phelps, E. A.; Garcia, A. J. Update on therapeutic vascularization strategies Regen. Med. 2009, 4, 65-80
2. Rouwkema, J.; Rivron, N. C.; van Blitterswijk, C. A. Vascularization in tissue engineering Trends Biotechnol. 2008, 26, 434-441
3. Novosel, E. C.; Kleinhans, C.; Kluger, P. J. Vascularization is the key challenge in tissue engineering Adv. Drug Delivery Rev. 2011, 63, 300-311
4. Carmeliet, P. Angiogenesis in life, disease and medicine Nature 2005, 438, 932-936
5. Presta, M.; Dell'Era, P.; Mitola, S.; Moroni, E.; Ronca, R.; Rusnati, M. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis Cytokine Growth Factor Rev. 2005, 16, 159-178
6. Formiga, F. R.; Pelacho, B.; Garbayo, E.; Abizanda, G.; Gavira, J. J.; Simon-Yarza, T.; Mazo, M.; Tamayo, E.; Jauquicoa, C.; Ortiz-de-Solorzano, C.; Prósper, F.; Blanco-Prieto, M. J. Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia-reperfusion model J. Controlled Release 2010, 147, 30-37
7. Fu, K.; Klibanov, A. M.; Langer, R. Protein stability in controlled-release systems Nat. Biotechnol. 2000, 18, 24-25
8. Guo, R.; Xu, S.; Ma, L.; Huang, A.; Gao, C. The healing of full-thickness burns treated by using plasmid DNA encoding VEGF-165 activated collagen-chitosan dermal equivalents Biomaterials 2011, 32, 1019-1031
9. O'Rorke, S.; Keeney, M.; Pandit, A. Non-viral polyplexes: Scaffold mediated delivery for gene therapy Prog. Polym. Sci. 2010, 35, 441-458
10. Jiang, M.; Yang, J.; Zhang, C.; Liu, B.; Chan, K.; Cao, H.; Lu, A. Clinical studies with traditional Chinese medicine in the past decade and future research and development Planta Med. 2010, 76, 2048-2064
11. Chen, X.; Peng, L.; Li, N.; Li, Q.; Li, P.; Fung, K.; Leung, P.; Gao, J. The healing and anti-scar effects of astragaloside IV on the wound repair in vitro and in vivo J. Ethnopharmacol. 2012, 139, 721-727
12. Zhang, Y.; Hu, G.; Li, S.; Li, Z. H.; Lam, C. O.; Hong, S. J.; Kwan, Y. W.; Chan, S. W.; Leung, G. P.; Lee, S. M. Pro-angiogenic activity of astragaloside IV in HUVECs in vitro and zebrafish in vivo Mol. Med. Rep. 2012, 5, 805-811
13. Zhang, L.; Liu, Q.; Lu, L.; Zhao, X.; Gao, X.; Wang, Y. Astragaloside IV stimulates angiogenesis and increases hypoxia-inducible factor-1alpha accumulation via phosphatidylinositol 3-kinase/Akt pathway J. Pharmacol. Exp. Ther. 2011, 338, 485-491
14. Zhang, J.; Liu, Y. L. H.; Zhang, X. Sodium ferulate protects against ischemia-reperfusion induced oxidative DNA damage in rat brain Chin. J. Neurosci. 2001, 17, 198-200
15. Wang, J.; Yuan, Z.; Zhao, H.; Ju, D.; Chen, Y.; Chen, X.; Zhang, J. Ferulic acid promotes endothelial cells proliferation through up-regulating cyclin D1 and VEGF J. Ethnopharmacol. 2011, 137, 992-997
16. Lin, C.; Chiu, J.; Wu, I.; Wang, B.; Pan, C.; Chen, Y. Ferulic acid augments angiogenesis via VEGF, PDGF and HIF-1α J. Nutr. Biochem. 2010, 21, 627-633
17. Greiner, A.; Wendorff, J. H. Electrospinning: A fascinating method for the preparation of ultrathin fibers Angew. Chem., Int. Ed. 2007, 46, 5670-5703
18. Zhang, X.; Baughman, C. B.; Kaplan, D. L. In vitro evaluation of electrospun silk fibroin scaffolds for vascular cell growth Biomaterials 2008, 29, 2217-2227
19. Montero, R. B.; Vial, X.; Nguyen, D. T.; Farhand, S.; Reardon, M.; Pham, S. M.; Tsechpenakis, G.; Andreopoulos, F. M. bFGF-containing electrospun gelatin scaffolds with controlled nano-architectural features for directed angiogenesis Acta Biomater. 2012, 8, 1778-1791
20. He, S.; Xia, T.; Wang, H.; Wei, L.; Luo, X.; Li, X. Multiple release of polyplexes of plasmids VEGF and bFGF from electrospun fibrous scaffolds towards regeneration of mature blood vessels Acta Biomater. 2012, 8, 2659-2669
21. Zhang, W.; Zhang, C.; Liu, R.; Li, H.; Zhang, J.; Mao, C.; Moran, S.; Chen, C. Preclinical pharmacokinetics and tissue distribution of a natural cardioprotective agent astragaloside IV in rats and dogs Life Sci. 2006, 79, 808-815
22. Li, D.; Zhong, X.; Zeng, Z.; Jiang, J.; Li, L.; Zhao, M.; Yang, X.; Chen, J.; Zhang, B.; Zhao, Q.; Xie, M.; Xiong, H.; Deng, Z.; Zhang, X.; Xu, S.; Gao, Y. Application of targeted drug delivery system in Chinese medicine J. Controlled Release 2009, 138, 103-112
23. Zhao, R. Z.; Liu, S. J. TCM medicinal guide theory and target-tropism administration J. Tradit. Chin. Med. 2005, 46, 643-645
24. Deng, X. M.; Li, X. H.; Yuan, M. L.; Xiong, C. D.; Huang, Z. T.; Jia, W. X.; Zhang, Y. H. Optimization of preparative conditions for poly-DL-lactide- polyethylene glycol microspheres with entrapped Vibrio Cholera antigens J. Controlled Release 1999, 58, 123-131
25. Li, G. C.; Yang, P.; Qin, W.; Maitz, M. F.; Zhou, S.; Huang, N. The effect of coimmobilizing heparin and fibronectin on titanium on hemocompatibility and endothelialization Biomaterials 2011, 32, 4691-4703
26. 2 surfaces for in situ catalytic generation of nitric oxide and potential application in intravascular stents Biomaterials 2011, 32, 1253-1263
27. Cui, W.; Li, X.; Zhu, X.; Yu, G.; Zhou, S.; Weng, J. Investigation of drug release and matrix degradation of electrospun poly(DL-lactide) fibers with paracetanol inoculation Biomacromolecules 2006, 7, 1623-1629
28. Liu, Y. Q.; Ding, M.; Xu, B. J. Determination of astragaloside in anisic acid-sulphuric acid system by spectrophotofluorimetry Acta Pharm. Sin. 2000, 35, 544-546
29. Peng, H.; Fu, J.; Yu, R. Determination of compound angelica injection Lishizhen Med. Mater. Med. Res. 2009, 20, 2925-2927
30. Zhu, X.; Cui, W.; Li, X.; Jin, Y. Electrospun fibrous mats with high porosity as potential scaffolds for skin tissue engineering Biomacromolecules 2008, 9, 1795-1801
31. Masaki, I.; Yonemitsu, Y.; Yamashita, A.; Sata, S.; Tanii, M.; Komori, K.; Nakagawa, K.; Hou, X.; Nagai, Y.; Hasegawa, M. Angiogenic gene therapy for experimental critical limb ischemia acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2 Circ. Res. 2002, 90, 966-973
32. Hou, Y. Z.; Yang, J.; Zhao, G. R.; Yuan, Y. J. Ferulic acid inhibits vascular smooth muscle cell proliferation induced by angiotensin II Eur. J. Pharmacol. 2004, 499, 85-90
33. Ma, Z.; Kotaki, M.; Yong, T.; He, W.; Ramakrishna, S. Surface engineering of electrospun polyethylene terephthalate (PET) nanofibers towards development of a new material for blood vessel engineering Biomaterials 2005, 26, 2527-2536
34. Kelleher, C. M.; McLean, S. E.; Mecham, R. P. Vascular extracellular matrix and aortic development Curr. Top. Dev. Biol. 2004, 62, 153-188
35. Adelöw, C.; Segura, T.; Hubbell, J. A.; Frey, P. The effect of enzymatically degradable poly(ethylene glycol) hydrogels on smooth muscle cell phenotype Biomaterials 2008, 29, 314-326
36. Nickel, J. C.; Roehrborn, C. G.; O'Leary, M. P.; Bostwick, D. G.; Somerville, M. C.; Rittmaster, R. S. The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial Eur. Urol. 2008, 54, 1379-1384
37. Jacob, M. P. Extracellular matrix remodeling and matrix metalloproteinases in the vascular wall during aging and in pathological conditions Biomed. Pharmacother. 2003, 57, 195-202
38. Taylor, A. P.; Rodriguez, M.; Adams, K.; Goldenberg, D. M.; Blumenthal, R. D. Altered tumor vessel maturation and proliferation in placenta growth factor-producing tumors: potential relationship to post-therapy tumor angiogenesis and recurrence Int. J. Cancer 2003, 105, 158-164
39. Nillesen, S. T. M.; Geutjes, P. J.; Wismans, R.; Schalkwijk, J.; Daamen, W. F.; van Kuppevelt, T. H. Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF Biomaterials 2007, 28, 1123-1131
40. Yancopoulos, G. D.; Davis, S.; Gale, N. W.; Rudge, J. S.; Wiegand, S. J.; Holash, J. Vascular-specific growth factors and blood vessel formation Nature 2000, 407, 242-248
41. Yang, L.; Dou, W. Y. C.; Liu, T.; Wei, D. Study on toxicity of angelica sinensis injection and astragalus membranaceus injection in chorioallantoic membrane model Chin. J. Exp. Tradit. Med. Formulae 2008, 14, 51-54
42. Li, Y.; Zhang, J.; Xue, L. Culture of human umbilica vein endothelial cells in vitro and effects of astragalus membranaceus and angelica sinensis on vascular endothelial growth factor J. Xinjiang Med. Univ. 2005, 28, 224-227